|
Comparison of biofilm formation ability among Candida clinical isolates. (click for details) |
|
|
|
Effectiveness of a regimen including a prophylaxis with voriconazole to prevent earlyonset
invasive aspergillosis in lung transplant recipients (click for details) |
|
|
|
Diagnostic and therapeutical aspects in a Dog Chronic Rhinitis caused by Aspergillus
Fumigatus and Cryptococcus Laurentii (click for details) |
|
|
|
In vitro antifungal activity of [2-(methacryloyloxy)ethyl]trimethylammonium chloride
against Candida sp. (click for details) |
|
|
|
In vitro-in vivo correlation for posaconazole and voriconazole against aspergillosis (click for details) |
|
|
|
Antifungal prophylaxis in acute myeloid leukemia and high-risk myelodysplastic
patients: a single centre experience (click for details) |
|
|
|
In vitro susceptibilities of invasive Candida spp. isolated from Austrian patients against
echonocandins and the commonly used azoles fluconazole and voriconazole (click for details) |
|
|
|
Histopathological diagnosis of onychomycosis using calcofluor white (CW) stain:
comparison with PAS staining of nail sections (click for details) |
|
|
|
Experimental models of pulmonary aspergillosis in domestic birds (click for details) |
|
|
|
Direct detection of multi-azole resistant Aspergillus fumigatus in brain tissue (click for details) |
|
|
